Skip to main content
Veterinary Medicines

IZOASPERSORIO

Authorised
  • Sulfaguanidine
  • Sulfanilamide
  • CHLORTETRACYCLINE HYDROCHLORIDE
  • Benzylpenicillin sodium

Product identification

Medicine name:
IZOASPERSORIO
Active substance:
  • Sulfaguanidine
  • Sulfanilamide
  • CHLORTETRACYCLINE HYDROCHLORIDE
  • Benzylpenicillin sodium
Target species:
  • Dog
  • Goat
  • Horse (non food-producing)
  • Cat
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Sulfaguanidine
    10.00
    gram(s)
    /
    1.00
    gram(s)
  • Sulfanilamide
    40.00
    gram(s)
    /
    1.00
    gram(s)
  • CHLORTETRACYCLINE HYDROCHLORIDE
    2.00
    gram(s)
    /
    1.00
    gram(s)
  • Benzylpenicillin sodium
    1000000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Cutaneous powder
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Goat
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse (non food-producing)
    • Cat
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD06C
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Izo S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Unione Commerciale Lombarda S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."